Effects of Panax ginseng on tumor necrosis factor-α-mediated inflammation: A mini-review

Molecules

Volumn 16, Issue 4, 2011, Pages 2802-2816

  Lee, Davy C W ^a   Lau, Allan S Y ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cytokines; Ginsenosides; Immunomodulation; Inflammation; Panax ginseng

Indexed keywords

PLANT EXTRACT; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; CELL LINE; CHEMISTRY; GINSENG; INFLAMMATION; MOUSE; PHYSIOLOGY; REVIEW;

ANIMALS; CELL LINE; INFLAMMATION; MICE; PANAX; PLANT EXTRACTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79955545463     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16042802     Document Type: Review

References (79)

1. Yun, T.K. Brief introduction of Panax ginseng C.A. Meyer. J. Korean Med. Sci. 2001, 16, S3-S5.
2. Gillis, C.N. Panax ginseng pharmacology: A nitric oxide link? Biochem. Pharmacol. 1997, 54, 1-8. (Pubitemid 27353216)
3. Yue, P.Y.; Mak, N.K.; Cheng, Y.K.; Leung, K.W.; Ng, T.B.; Fan, D.T.; Yeung, H.W.; Wong, R.N. Pharmacogenomics and the Yin/Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin. Med. 2007, 2, 6.
4. Attele, A.S.; Wu, J.A.; Yuan, C.S. Ginseng pharmacology: Multiple constituents and multiple actions. Biochem. Pharmacol. 1999, 58, 1685-1693. (Pubitemid 29505408)
5. Chang, S.H.; Choi, Y.; Park, J.A.; Jung, D.S.; Shin, J.; Yang, J.H.; Ko, S.Y.; Kim, S.W.; Kim, J.K. Anti-inflammatory effects of BT-201, an n-butanol extract of Panax notoginseng, observed in vitro and in a collagen-induced arthritis model. Clin. Nutr. 2007, 26, 785-791. (Pubitemid 350103046)
6. Zhang, Y.G.; Zhang, H.G.; Zhang, G.Y.; Fan, J.S.; Li, X.H.; Liu, Y.H.; Li, S.H.; Lian, X.M.; Tang, Z. Panax notoginseng saponins attenuate atherosclerosis in rats by regulating the blood lipid profile and an anti-inflammatory action. Clin. Exp. Pharmacol. Physiol. 2008, 35, 1238-1244.
7. Wan, J.B.; Lee, S.M.; Wang, J.D.; Wang, N.; He, C.W.; Wang, Y.T.; Kang, J.X. Panax notoginseng reduces atherosclerotic lesions in ApoE-deficient mice and inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion. J. Agric. Food Chem. 2009, 57, 6692-6697.
8. Yun, T.K. Update from Asia. Asian studies on cancer chemoprevention. Ann. NY Acad. Sci. 1999, 889, 157-192.
9. Jia, L.; Zhao, Y. Current evaluation of the millennium phytomedicine-ginseng (I): Etymology, pharmacognosy, phytochemistry, market and regulations. Curr. Med. Chem. 2009, 16, 2475-2484.
10. Lee, M.; Sorn, S.; Baek, S.; Jang, S.; Kim, S. Antioxidant and apoptotic effects of korean white ginseng extracted with the same ratio of protopanaxadiol and protopanaxatriol saponins in human hepatoma HepG2 cells. Ann. NY Acad. Sci. 2009, 1171, 217-227.
11. Nah, S.Y.; Park, H.J.; McCleskey, E.W. A trace component of ginseng that inhibits Ca2+ channels through a pertussis toxin-sensitive G protein. Proc. Natl. Acad. Sci. USA 1995, 92, 8739-8743.
12. Sacca, R.; Cuff, C.A.; Ruddle, N.H. Mediators of inflammation. Curr. Opin. Immunol. 1997, 9, 851-857. (Pubitemid 28062271)
13. Dinarello, C.A. Anti-inflammatory agents: Present and future. Cell 2010, 140, 935-950.
14. Bradley, J.R. TNF-mediated inflammatory disease. J. Pathol. 2008, 214, 149-160. (Pubitemid 351160153)
15. Clark, I.A. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev. 2007, 18, 335-343. (Pubitemid 46891287)
16. Dinarello, C.A. Proinflammatory cytokines. Chest 2000, 118, 503-508. (Pubitemid 30637822)
17. Opal, S.M.; DePalo, V.A. Anti-inflammatory cytokines. Chest 2000, 117, 1162-1172. (Pubitemid 30228378)
18. Carriere, V.; Roussel, L.; Ortega, N.; Lacorre, D.A.; Americh, L.; Aguilar, L.; Bouche, G.; Girard, J.P. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc. Natl. Acad. Sci. USA 2007, 104, 282-287. (Pubitemid 46068023)
19. Dinarello, C.A. IL-1: Discoveries, controversies and future directions. Eur. J. Immunol. 2010, 40, 599-606.
20. Latz, E. The inflammasomes: mechanisms of activation and function. Curr. Opin. Immunol. 2010, 22, 28-33.
21. Onishi, R.M.; Gaffen, S.L. Interleukin-17 and its target genes: Mechanisms of interleukin-17 function in disease. Immunology 2010, 129, 311-321.
22. Pappu, R.; Ramirez-Carrozzi, V.; Ota, N.; Ouyang, W.; Hu, Y. The IL-17 family cytokines in immunity and disease. J. Clin. Immunol. 2010, 30, 185-195.
23. Liew, F.Y.; Pitman, N.I.; McInnes, I.B. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat. Rev. Immunol. 2010, 10, 103-110.
24. Mosser, D.M.; Zhang, X. Interleukin-10: New perspectives on an old cytokine. Immunol. Rev. 2008, 226, 205-218.
25. Kim, E.Y.; Moudgil, K.D. Regulation of autoimmune inflammation by pro-inflammatory cytokines. Immunol. Lett. 2008, 120, 1-5.
26. Park, K.M.; Bowers, W.J. Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction. Cell Signal 2010, 22, 977-983.
27. Hehlgans, T.; Pfeffer, K. The intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the games. Immunology 2005, 115, 1-20. (Pubitemid 40598088)
28. Chen, G.; Goeddel, D.V. TNF-R1 signaling: a beautiful pathway. Science 2002, 296, 1634-1635. (Pubitemid 34579145)
29. Aggarwal, B.B. Signalling pathways of the TNF superfamily: A double-edged sword. Nat. Rev. Immunol. 2003, 3, 745-756. (Pubitemid 41070815)
30. Radad, K.; Gille, G.; Liu, L.; Rausch, W.D. Use of ginseng in medicine with emphasis on neurodegenerative disorders. J. Pharmacol. Sci. 2006, 100, 175-186.
31. Ho, L.J.; Juan, T.Y.; Chao, P.; Wu, W.L.; Chang, D.M.; Chang, S.Y.; Lai, J.H. Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha- NF-kappaB signaling pathway in human peripheral blood T cell. Br. J. Pharmacol. 2004, 143, 919-927. (Pubitemid 39664851)
32. Mizuno, M.; Yamada, J.; Terai, H.; Kozukue, N.; Lee, Y.S.; Tsuchida, H. Differences in immunomodulating effects between wild and cultured Panax ginseng. Biochem. Biophys. Res. Commun. 1994, 200, 1672-1678. (Pubitemid 24181845)
33. Nakaya, T.A.; Kita, M.; Kuriyama, H.; Iwakura, Y.; Imanishi, J. Panax ginseng induces production of proinflammatory cytokines via toll-like receptor. J. Interferon Cytokine Res. 2004, 24, 93-100. (Pubitemid 38253636)
34. Shin, J.Y.; Song, J.Y.; Yun, Y.S.; Yang, H.O.; Rhee, D.K.; Pyo, S. Immunostimulating effects of acidic polysaccharides extract of Panax ginseng on macrophage function. Immunopharmacol. Immunotoxicol. 2002, 24, 469-482.
35. Sonoda, Y.; Kasahara, T.; Mukaida, N.; Shimizu, N.; Tomoda, M.; Takeda, T. Stimulation of interleukin-8 production by acidic polysaccharides from the root of Panax ginseng. Immunopharmacology 1998, 38, 287-294. (Pubitemid 28064599)
36. Tan, B.K.; Vanitha, J. Immunomodulatory and antimicrobial effects of some traditional chinese medicinal herbs: A review. Curr. Med. Chem. 2004, 11, 1423-1430. (Pubitemid 38735787)
37. Song, X.; Hu, S. Adjuvant activities of saponins from traditional Chinese medicinal herbs. Vaccine 2009, 27, 4883-4890.
38. Ahn, J.Y.; Choi, I.S.; Shim, J.Y.; Yun, E.K.; Yun, Y.S.; Jeong, G.; Song, J.Y. The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals. Eur. J. Immunol. 2006, 36, 37-45. (Pubitemid 43116390)
39. Ahn, J.Y.; Song, J.Y.; Yun, Y.S.; Jeong, G.; Choi, I.S. Protection of Staphylococcus aureus-infected septic mice by suppression of early acute inflammation and enhanced antimicrobial activity by ginsan. FEMS Immunol. Med. Microbiol. 2006, 46, 187-197.
40. Lim, Y.J.; Na, H.S.; Yun, Y.S.; Choi, I.S.; Oh, J.S.; Rhee, J.H.; Cho, B.H.; Lee, H.C. Suppressive effects of ginsan on the development of allergic reaction in murine asthmatic model. Int. Arch. Allergy Immunol. 2009, 150, 32-42.
41. Shim, J.Y.; Kim, M.H.; Kim, H.D.; Ahn, J.Y.; Yun, Y.S.; Song, J.Y. Protective action of the immunomodulator ginsan against carbon tetrachloride-induced liver injury via control of oxidative stress and the inflammatory response. Toxicol. Appl. Pharmacol. 2010, 242, 318-325.
42. Kim, M.H.; Byon, Y.Y.; Ko, E.J.; Song, J.Y.; Yun, Y.S.; Shin, T.; Joo, H.G. Immunomodulatory activity of ginsan, a polysaccharide of Panax ginseng, on dendritic cells. Korean J. Physiol. Pharmacol. 2009, 13, 169-173.
43. Peng, X.D.; Dai, L.L.; Huang, C.Q.; He, C.M.; Yang, B.; Chen, L.J. Relationship between anti-fibrotic effect of Panax notoginseng saponins and serum cytokines in rat hepatic fibrosis. Biochem. Biophys. Res. Commun. 2009, 388, 31-34.
44. Rhule, A.; Rase, B.; Smith, J.R.; Shepherd, D.M. Toll-like receptor ligand-induced activation of murine DC2.4 cells is attenuated by Panax notoginseng. J. Ethnopharmacol. 2008, 116, 179-186.
45. Ichikawa, T.; Li, J.; Nagarkatti, P.; Nagarkatti, M.; Hofseth, L.J.; Windust, A.; Cui, T. American ginseng preferentially suppresses STAT/iNOS signaling in activated macrophages. J. Ethnopharmacol. 2009, 125, 145-150.
46. Jin, Y.; Kotakadi, V.S.; Ying, L.; Hofseth, A.B.; Cui, X.; Wood, P.A.; Windust, A.; Matesic, L.E.;Pena, E.A.; Chiuzan, C.; Singh, N.P.; Nagarkatti, M.; Nagarkatti, P.S.; Wargovich, M.J.; Hofseth, L.J. American ginseng suppresses inflammation and DNA damage associated with mouse colitis. Carcinogenesis 2008, 29, 2351-2359.
47. Chai, H.; Wang, Q.; Huang, L.; Xie, T.; Fu, Y. Ginsenoside Rb1 inhibits tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Biol. Pharm. Bull. 2008, 31, 2050-2056.
48. Huang, J.; Qiu, L.; Ding, L.; Wang, S.; Wang, J.; Zhu, Q.; Song, F.; Hu, J. Ginsenoside Rb1 and paeoniflorin inhibit transient receptor potential vanilloid-1-activated IL-8 and PGE production in a human keratinocyte cell line HaCaT. Int. Immunopharmacol. 2010, 10, 1279-1283.
49. Kim, H.A.; Kim, S.; Chang, S.H.; Hwang, H.J.; Choi, Y.N. Anti-arthritic effect of ginsenoside Rb1 on collagen induced arthritis in mice. Int. Immunopharmacol. 2007, 7, 1286-1291. (Pubitemid 47126366)
50. Ye, R.; Yang, Q.; Kong, X.; Han, J.; Zhang, X.; Zhang, Y.; Li, P.; Liu, J.; Shi, M.; Xiong, L.; Zhao, G. Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats. Neurochem. Int. 2010, 58, 391-398.
51. Hu, J.F.; Song, X.Y.; Chu, S.F.; Chen, J.; Ji, H.J.; Chen, X.Y.; Yuan, Y.H.; Han, N.; Zhang, J.T.; Chen, N.H. Inhibitory effect of ginsenoside Rg1 on lipopolysaccharide-induced microglial activation in mice. Brain Res. 2011, 1374, 8-14.
52. Wu, C.F.; Bi, X.L.; Yang, J.Y.; Zhan, J.Y.; Dong, Y.X.; Wang, J.H.; Wang, J.M.; Zhang, R.; Li, X. Differential effects of ginsenosides on NO and TNF-alpha production by LPS-activated N9 microglia. Int. Immunopharmacol. 2007, 7, 313-320. (Pubitemid 46186170)
53. Lee, J. H.; Han, Y., Ginsenoside Rg1 helps mice resist to disseminated candidiasis by Th1 type differentiation of CD4+ T cell. Int. Immunopharmacol. 2006, 6, 1424-1430. (Pubitemid 44038684)
54. Keum, Y.S.; Han, S.S.; Chun, K.S.; Park, K.K.; Park, J.H.; Lee, S.K.; Surh, Y.J. Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutat. Res. 2003, 523-524, 75-85. (Pubitemid 36293234)
55. Joo, S.S.; Yoo, Y.M.; Ahn, B.W.; Nam, S.Y.; Kim, Y.B.; Hwang, K.W.; Lee do, I. Prevention of inflammation-mediated neurotoxicity by Rg3 and its role in microglial activation. Biol. Pharm. Bull. 2008, 31, 1392-1396. (Pubitemid 351930653)
56. Min, J.K.; Kim, J.H.; Cho, Y.L.; Maeng, Y.S.; Lee, S.J.; Pyun, B.J.; Kim, Y.M.; Park, J.H.; Kwon, Y.G. 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochem. Biophys. Res. Commun. 2006, 349, 987-994. (Pubitemid 44380196)
57. Hien, T.T.; Kim, N.D.; Kim, H.S.; Kang, K.W. Ginsenoside Rg3 inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules in human endothelial cells. Pharmazie 2010, 65, 699-701.
58. Jung, J.S.; Kim, D.H.; Kim, H.S. Ginsenoside Rh1 suppresses inducible nitric oxide synthase gene expression in IFN-gamma-stimulated microglia via modulation of JAK/STAT and ERK signaling pathways. Biochem. Biophys. Res. Commun. 2010, 397, 323-328.
59. Jung, J.S.; Shin, J.A.; Park, E.M.; Lee, J.E.; Kang, Y.S.; Min, S.W.; Kim, D.H.; Hyun, J.W.; Shin, C.Y.; Kim, H.S. Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide-stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase-1 expression. J. Neurochem. 2010, 115, 1668-1680.
60. Zheng, H.; Jeong, Y.; Song, J.; Ji, G.E. Oral administration of ginsenoside Rh1 inhibits the development of atopic dermatitis-like skin lesions induced by oxazolone in hairless mice. Int. Immunopharmacol. 2011, 11, 511-518.
61. Park, E.K.; Choo, M.K.; Han, M.J.; Kim, D.H. Ginsenoside Rh1 possesses antiallergic and anti-inflammatory activities. Int. Arch. Allergy Immunol. 2004, 133, 113-120. (Pubitemid 38314642)
62. Oh, G.S.; Pae, H.O.; Choi, B.M.; Seo, E.A.; Kim, D.H.; Shin, M.K.; Kim, J.D.; Kim, J.B.; Chung, H.T. 20(S)-Protopanaxatriol, one of ginsenoside metabolites, inhibits inducible nitric oxide synthase and cyclooxygenase-2 expressions through inactivation of nuclear factor-kappaB in RAW 264.7 macrophages stimulated with lipopolysaccharide. Cancer Lett. 2004, 205, 23-29. (Pubitemid 38230135)
63. Choi, K.; Kim, M.; Ryu, J.; Choi, C. Ginsenosides compound K and Rh(2) inhibit tumor necrosis factor-alpha-induced activation of the NF-kappaB and JNK pathways in human astroglial cells. Neurosci. Lett. 2007, 421, 37-41. (Pubitemid 46899328)
64. Bae, E.A.; Kim, E.J.; Park, J. S.; Kim, H. S.; Ryu, J. H.; Kim, D. H., Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon -gamma-stimulated BV-2 microglial cells. Planta Med. 2006, 72, 627-633.
65. Park, J.S.; Park, E.M.; Kim, D.H.; Jung, K.; Jung, J.S.; Lee, E.J.; Hyun, J.W.; Kang, J.L.; Kim, H.S. Anti-inflammatory mechanism of ginseng saponins in activated microglia. J. Neuroimmunol. 2009, 209, 40-49.
66. Kim, B.H.; Lee, Y.G.; Park, T.Y.; Kim, H.B.; Rhee, M.H.; Cho, J.Y. Ginsenoside Rp1, a ginsenoside derivative, blocks lipopolysaccharide-induced interleukin-1beta production via suppression of the NF-kappaB pathway. Planta Med. 2009, 75, 321-326.
67. Lee, D.C.; Yang, C.L.; Chik, S.C.; Li, J.C.; Rong, J.H.; Chan, G.C.; Lau, A.S. Bioactivity-guided identification and cell signaling technology to delineate the immunomodulatory effects of Panax ginseng on human promonocytic U937 cells. J. Transl. Med. 2009, 7, 34.
68. Barbara, J.A.; Van ostade, X.; Lopez, A. Tumour necrosis factor-alpha (TNF-alpha): the good, the bad and potentially very effective. Immunol. Cell Biol. 1996, 74, 434-443. (Pubitemid 26342128)
69. Pfeffer, K.; Matsuyama, T.; Kundig, T.M.; Wakeham, A.; Kishihara, K.; Shahinian, A.; Wiegmann, K.; Ohashi, P.S.; Kronke, M.; Mak, T.W. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 1993, 73, 457-467. (Pubitemid 23143346)
70. Rothe, J.; Lesslauer, W.; Lotscher, H.; Lang, Y.; Koebel, P.; Kontgen, F.; Althage, A.; Zinkernagel, R.; Steinmetz, M.; Bluethmann, H. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 1993, 364, 798-802. (Pubitemid 23261759)
71. Pasparakis, M.; Kousteni, S.; Peschon, J.; Kollias, G. Tumor necrosis factor and the p55TNF receptor are required for optimal development of the marginal sinus and for migration of follicular dendritic cell precursors into splenic follicles. Cell. Immunol. 2000, 201, 33-41. (Pubitemid 30337706)
72. Flynn, J.L.; Goldstein, M.M.; Chan, J.; Triebold, K.J.; Pfeffer, K.; Lowenstein, C.J.; Schreiber, R.; Mak, T.W.; Bloom, B.R. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995, 2, 561-572.
73. Elenkov, I.J.; Chrousos, G.P. Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Ann. NY Acad. Sci. 2002, 966, 290-303. (Pubitemid 34729188)
74. Beutler, B.; Cerami, A. The biology of cachectin/TNF-a primary mediator of the host response. Annu. Rev. Immunol. 1989, 7, 625-655. (Pubitemid 19138027)
75. Atzeni, F.; Turiel, M.; Capsoni, F.; Doria, A.; Meroni, P.; Sarzi-Puttini, P. Autoimmunity and anti-TNF-alpha agents. Ann. NY Acad. Sci. 2005, 1051, 559-569.
76. Kassiotis, G.; Kollias, G. Uncoupling the proinflammatory from the immunosuppressive properties of tumor necrosis factor (TNF) at the p55 TNF receptor level: implications for pathogenesis and therapy of autoimmune demyelination. J. Exp. Med. 2001, 193, 427-434. (Pubitemid 32524474)
77. Kollias, G.; Douni, E.; Kassiotis, G.; Kontoyiannis, D. On the role of tumor necrosis factor and receptors in models of multiorgan failure, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease. Immunol. Rev. 1999, 169, 175-194. (Pubitemid 29338732)
78. Queiroz, E.F.; Wolfender, J.L.; Hostettmann, K. Modern approaches in the search for new lead antiparasitic compounds from higher plants. Curr. Drug Targets 2009, 10, 202-211.
79. Jiang, Y.; David, B.; Tu, P.; Barbin, Y. Recent analytical approaches in quality control of traditional Chinese medicines-A review. Anal. Chim. Acta 2010, 657, 9-18.